The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...

Diabetes, affecting over 100 million adults in India, poses severe risks to the heart and kidneys. High blood sugar damages ...

Doctors recommend everyone eat a balanced diet and adopt an exercise routine to stay healthy. The holiday season with all the ...

Beetroot juice is a valuable addition to a diabetic diet, offering benefits like improved blood sugar control, reduced blood ...

The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, ...

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

Discover how SGLT-2 inhibitors improve survival and reduce cardiac and kidney risks in diabetic kidney transplant recipients.

A research group led by Osaka Metropolitan University has studied how SGLT2 inhibitors, a class of drugs that help the ...

But while the benefits of GLP-1 receptor agonists for the treatment of type 2 diabetes, obesity and cardiovascular disease are well known, their impact on chronic kidney disease (CKD) has been ...

November is Diabetes and Kidney Disease Awareness month, and a great time to find out how you can protect yourself from a ...